Catalyst Wire Dossier Catalyst Wire Dossier

liprotamase unit-matched therapy (non-porcine origin)

liprotamase unit-matched therapy (non-porcine origin) · Anthera Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for liprotamase unit-matched therapy (non-porcine origin), covering 2018-08-14 to 2018-08-14. Get the full timeline:

Most recent: Clinical Trial Update: SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis [Phase 3]

See pricing